Psychedelics

A class of psychoactive substances, including psilocybin, MDMA, and ibogaine, undergoing regulatory reclassification and clinical research for therapeutic use in mental health.

Foresight reads official sources for Psychedelics, such as regulators' notices, legislative records and published guidance. Each alert says what changed and links to where it was published. Coverage varies by market, so scoping starts with where you sell.

It compares Psychedelics's alerts over the latest four weeks with the eight weeks before. Alerts are rising when the latest four weeks average at least a fifth more a week, and at least one more. They are falling when they drop as far, and holding steady in between. After four weeks with no alert, the page shows when the latest one came instead.

Yes. Horizon scanning scores each new Psychedelics alert against your products, substances and markets, most important first, with the reason it matters to you and its source.